A Multidisciplinary Approach for Improving Quality of Life and Self-Management in Diabetic Kidney Disease: A Crossover Study
- PMID: 32650548
- PMCID: PMC7408890
- DOI: 10.3390/jcm9072160
A Multidisciplinary Approach for Improving Quality of Life and Self-Management in Diabetic Kidney Disease: A Crossover Study
Abstract
Individuals with diabetic kidney disease are at high risk of complications and challenged to self-manage. Previous research suggested that multidisciplinary approaches would improve health outcomes. This study investigated the effect of a multidisciplinary self-management approach of diabetic kidney disease on quality of life, and self-management, glycemic control, and renal function. A uniform balanced crossover design was used because it attains a high level of statistical power with a lower sample size. A total of 32 participants (aged 67.8 ± 10.8) were randomized into four study arms. In differing sequences, each participant was treated twice with three months of usual care alternated with three months of multidisciplinary management. The intervention improved the present dimension of quality of life demonstrating higher mean rank as compared to usual care (52.49 vs. 41.01; p = 0.026, 95% CI) and three self-care activities, general diet habits, diabetes diet habits, and blood sugar testing (respectively: 55.43 vs. 38.31; p = 0.002, 56.84 vs. 37.02; p = 0.000, 53.84 vs. 39.77; p = 0.008; 95% CI). Antihypertensive medication engagement was high across the study period (Mean = 95.38%, Min = 69%, Max = 100%). Glycemic control and renal function indicators were similar for the intervention and the usual care. Studies are needed to determine how the new recommended therapies for diabetic kidney disease such as SGLT2 inhibitors and GLP-1 receptor agonists impact on self-management and quality of life.
Keywords: diabetic nephropathy; interdisciplinary studies; multidisciplinary care; randomized crossover; self-management interventions; self-management support.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
References
-
- Lu Y., Stamm C., Nobre D., Pruijm M., Teta D., Cherpillod A., Halabi G., Phan O., Fumeaux Z., Bullani R. Changing trends in end-stage renal disease patients with diabetes. Swiss Med. Wkly. 2017;147:w14458. - PubMed
-
- KDIGO CKD Evaluation and Management–KDIGO. [(accessed on 8 January 2020)]; Available online: https://kdigo.org/guidelines/ckd-evaluation-and-management/
-
- United States Renal Data System . USRDS 2016 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD, USA: 2016.
-
- Tonelli M., Muntner P., Lloyd A., Manns B.J., Klarenbach S., Pannu N., James M.T., Hemmelgarn B.R., Alberta Kidney Disease Network Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study. Lancet. 2012;380:807–814. doi: 10.1016/S0140-6736(12)60572-8. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
